These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7254280)

  • 1. Biologic differences between neuroblastoma stages IV-S and IV. Measurement of serum ferritin and E-rosette inhibition in 30 children.
    Hann HW; Evans AE; Cohen IJ; Leitmeyer JE
    N Engl J Med; 1981 Aug; 305(8):425-9. PubMed ID: 7254280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experience.
    Hann HW; Evans AE; Siegel SE; Wong KY; Sather H; Dalton A; Hammond D; Seeger RC
    Cancer Res; 1985 Jun; 45(6):2843-8. PubMed ID: 3986811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences between neuroblastoma stages IV-S and IV.
    N Engl J Med; 1981 Dec; 305(23):1418-9. PubMed ID: 7300864
    [No Abstract]   [Full Text] [Related]  

  • 4. Models to predict outcome from childhood neuroblastoma: the role of serum ferritin and tumor histology.
    Silber JH; Evans AE; Fridman M
    Cancer Res; 1991 Mar; 51(5):1426-33. PubMed ID: 1997181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum ferritin as a prognostic indicator in neuroblastoma: biological effects of isoferritins.
    Hann HW; Stahlhut MW; Evans AE
    Prog Clin Biol Res; 1985; 175():331-45. PubMed ID: 3873075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
    Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
    Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biological indicators with a prognostic significance in neuroblastoma in children].
    Pein F; Hartmann O
    Bull Cancer; 1988; 75(1):83-6. PubMed ID: 3359058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum ferritin as a guide to therapy in neuroblastoma.
    Hann HW; Levy HM; Evans AE
    Cancer Res; 1980 May; 40(5):1411-3. PubMed ID: 6245792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroblastoma in the first year of life: clinical and biologic factors influencing outcome.
    Grosfeld JL; Rescorla FJ; West KW; Goldman J
    Semin Pediatr Surg; 1993 Feb; 2(1):37-46. PubMed ID: 8062021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin in stage IV neuroblastoma.
    Imashuku S; Yamanaka H; Morioka Y; Todo S
    Am J Pediatr Hematol Oncol; 1988; 10(1):39-41. PubMed ID: 3189716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroblastoma in adolescents: the Italian experience.
    Conte M; Parodi S; De Bernardi B; Milanaccio C; Mazzocco K; Angelini P; Viscardi E; Di Cataldo A; Luksch R; Haupt R
    Cancer; 2006 Mar; 106(6):1409-17. PubMed ID: 16475209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leukoerythroblastosis as a manifestation of disseminated neuroblastoma in childhood].
    Couselo Sánchez JM; Méndez Rodríguez I; Fuster Siebert M; Castro Gago M; Monasterio Corral L; Iglesias Diz L
    Rev Esp Oncol; 1980; 27(4):571-8. PubMed ID: 7268159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of prognostic factors in the Austrian A-NB87 Neuroblastoma Study].
    Ladenstein R; Ambros PF; Urban C; Ambros IM; Fink FM; Zoubek A; Grienberger H; Schmitt K; Kerbl R; Horcher E; Amann G; Höfler G; Heinzl H; Gadner H; Mutz I
    Klin Padiatr; 1996; 208(4):210-20. PubMed ID: 8926686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroblastoma.
    Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
    Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of natural antibody against human neuroblastoma among children with or without neuroblastoma.
    Fukuda M; Nozaki C; Ishiguro Y; Horibe K
    Med Pediatr Oncol; 2001 Jan; 36(1):147-8. PubMed ID: 11464870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroblastoma: biological markers, surgery, and clinical course].
    Martínez Ibáñez V; Abad P; Gallego S; Sánchez de Toledo J; Marqués A; Boix Ochoa J
    Cir Pediatr; 2000 Apr; 13(2):47-53. PubMed ID: 12602001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuroblastoma IV-S. A multicenter study. Work Group of Pediatric Oncology. Spanish Society of Pediatric Surgery].
    Rollán Villamarín V; García Aroca J; Costa Borrás E; Cuadros García J; Jiménez Alvarez C; Martínez-Caro A; Martínez Ibáñez V; Mulet Ferragut F; Obiols Arderius P; Pérez La Fuente G
    Cir Pediatr; 1994 Oct; 7(4):167-70. PubMed ID: 7865360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma.
    Moss TJ; Reynolds CP; Sather HN; Romansky SG; Hammond GD; Seeger RC
    N Engl J Med; 1991 Jan; 324(4):219-26. PubMed ID: 1985243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroblastoma at the Giannina Gaslini Institute. Analysis of 94 cases diagnosed 1972-1981].
    De Bernardi B; Garaventa A; Bartolini M; Rizzo A; Rosanda C; Bisogni C; Melodia A; Magnaguagno G; Ricci G; Lamedica G
    Pediatr Med Chir; 1983; 5(1-2):49-58. PubMed ID: 6634442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic features in 23 patients.
    Matthay KK; Brisse H; Couanet D; Couturier J; Bénard J; Mosseri V; Edeline V; Lumbroso J; Valteau-Couanet D; Michon J
    Cancer; 2003 Jul; 98(1):155-65. PubMed ID: 12833468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.